Interventional technology provider AngioDynamics said it would file a motion to overturn a verdict rendered against the firm yesterday in a patent infringement case involving Diomed of Andover, MA.
The jury verdict stems from a 2004 lawsuit filed by Diomed asserting patent infringement by AngioDynamics' VenaCure product line. The jury in the U.S. District Court for the District of Massachusetts in Boston found that the infringement was not willful, but awarded $8.36 million in compensatory monetary damages.
If the motion is denied, the Queensbury, NY-based firm said it would appeal the verdict in the U.S. Court of Appeals for the Federal Circuit in Washington, DC.
In other AngioDynamics news, the company has appointed Joseph Gersuk as senior vice president and chief financial officer (CFO), effective April 16. Gersuk has more than 25 years as a senior financial executive, AngioDynamics said.
By AuntMinnie.com staff writers
March 29, 2007
Related Reading
AngioDynamics unveils Smart Port CT, March 1, 2007
AngioDynamics wraps up RITA buy, January 30, 2007
AngioDynamics notches record Q2, January 4, 2007
AngioDynamics gets clearance for soft-tissue ablation technology, November 28, 2006
AngioDynamics to acquire RITA Medical, November 28, 2006
Copyright © 2007 AuntMinnie.com
